Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients

Biomarkers in Alzheimer’s disease: past, present and future

(2010) Katarzyna Gustaw-Rothenberg et al.   Biomarkers in Medicine

Cholesterol, Alzheimers Disease, Prion Disorders: A menage a trois?

(2010) Alessandra Pani et al.   CURRENT DRUG TARGETS

ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD

(2010) E. Y. Bryleva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease

(2009) Alessandra Pani et al.   BMC Medicine

The Role of Apolipoprotein E in Alzheimer's Disease

(2009) Jungsu Kim et al.   NEURON

Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease

(2008) George Perry et al.   CNS & Neurological Disorders-Drug Targets

Novel N-terminal Cleavage of APP Precludes Aβ Generation in ACAT-Defective AC29 Cells

(2008) Henri J. Huttunen et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

ACAT as a Drug Target for Alzheimer’s Disease

(2008) Henri J. Huttunen et al.   Neurodegenerative Diseases

Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease

(2008) Maria-Paz Marzolo et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?

(2008) David H. Small   TRENDS IN MOLECULAR MEDICINE

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

(2008) P. Hemachandra Reddy et al.   TRENDS IN MOLECULAR MEDICINE